CRY2 Antibody / Cryptochrome 2, Clone: [1819CT334.92.36.9], Mouse, Monoclonal

Catalog Number: NSJ-F54116-0.2ML
Article Name: CRY2 Antibody / Cryptochrome 2, Clone: [1819CT334.92.36.9], Mouse, Monoclonal
Biozol Catalog Number: NSJ-F54116-0.2ML
Supplier Catalog Number: F54116-0.2ML
Alternative Catalog Number: NSJ-F54116-0.2ML
Manufacturer: NSJ Bioreagents
Host: Mouse
Category: Antikörper
Application: WB
Species Reactivity: Human, Mouse
Immunogen: Recombinant human Cryptochrome 2 was used as the immunogen for the CRY2 antibody.
Cryptochrome 2 is a transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time- keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). CRY1 and CRY2 have redundant functions but also differential and selective contributions at least in defining the pace of the SCN circadian clock and its circadian transcriptional outputs. CRY2 is a less potent transcriptional repressor in cerebellum and liver than CRY1, though less effective in lengthening the period of the SCN oscillator and seems to play a critical role in tuning SCN circadian period by opposing the action of CRY1. [UniProt]
Clonality: Monoclonal
Clone Designation: [1819CT334.92.36.9]
UniProt: Q49AN0
Purity: Protein G purified
Form: In 1X PBS, pH 7.4, with 0.09% sodium azide
Antibody Type: Primary Antibody
Application Dilute: Western blot: 1:4000
Application Notes: The stated application concentrations are suggested starting points. Titration of the CRY2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.